Suppr超能文献

[隐花青染料NK-4对自然杀伤T细胞的激活作用]

[Activation of natural killer T cells by NK-4, a criptocyanine dye].

作者信息

Kunikata Toshio, Kohno Keizo, Ushio Shimpei, Fukuda Shigeharu

机构信息

Biomedical Institute, Research Center, Hayashibara Biochemical Laboratories, Inc., Okayama, Japan.

出版信息

Yakugaku Zasshi. 2011;131(11):1667-74. doi: 10.1248/yakushi.131.1667.

Abstract

We previously reported that oral administration of NK-4, a criptocyanine dye, enhances interleukin (IL)-12-depend- ent interferon (IFN)-γ production by lipopolysaccharide (LPS)-stimulated mouse splenocytes. These findings raised a possibility that NK-4 potentiated IFN-γ production by T cells, natural killer (NK) cells or natural killer T (NKT) cells in response to IL-12 produced by macrophage and dendritic cells. To explore this possibility, we first analyzed percentages of T, NK or NKT cells in splenocytes of mice that were administered NK-4 orally for three days. The percentage of NKT cells in splenocytes from NK-4-treated mice was significantly (p<0.05) increased compared to vehicle-treated mice. When splenocytes were stimulated with α-galactosylceramide (α-GalCer), an NKT cell ligand, IFN-γ production by splenocytes from NK-4-treated mice tended to increase, while no difference in the IL-4 production and proliferation were observed between the vehicle- and NK-4-treated mice. When IFN-γ/IL-4 ratios were calculated in individual mice, the ratios were significantly (p<0.05) elevated in NK-4-treated mice. Furthermore, IL-12 production by α-GalCer-stimulated splenocytes from NK-4-treated mice was also significantly (p<0.05) increased. These results suggest that oral administration of NK-4 increases the population of type I NKT cells with potent IFN-γ-producing activities. Since IL-12 and IFN-γ have been shown to play important roles in anti-tumor immunity as well as in the defence against bacterial infection, our results further imply that NK-4 may provide a potential therapeutic tool in cancer immunotherapy.

摘要

我们之前报道过,口服隐花青染料NK-4可增强脂多糖(LPS)刺激的小鼠脾细胞产生白细胞介素(IL)-12依赖性干扰素(IFN)-γ。这些发现提示,NK-4可能通过巨噬细胞和树突状细胞产生的IL-12增强T细胞、自然杀伤(NK)细胞或自然杀伤T(NKT)细胞产生IFN-γ。为探究这种可能性,我们首先分析了连续三天口服NK-4的小鼠脾细胞中T细胞、NK细胞或NKT细胞的百分比。与赋形剂处理的小鼠相比,NK-4处理小鼠脾细胞中NKT细胞的百分比显著增加(p<0.05)。当用NKT细胞配体α-半乳糖神经酰胺(α-GalCer)刺激脾细胞时,NK-4处理小鼠的脾细胞产生IFN-γ的量有增加趋势,而赋形剂处理组和NK-4处理组小鼠在IL-4产生和增殖方面未观察到差异。计算每只小鼠的IFN-γ/IL-4比值时,NK-4处理小鼠的比值显著升高(p<0.05)。此外,α-GalCer刺激的NK-4处理小鼠脾细胞产生IL-12的量也显著增加(p<0.05)。这些结果表明,口服NK-4可增加具有强大IFN-γ产生活性的I型NKT细胞数量。由于IL-12和IFN-γ在抗肿瘤免疫以及抵抗细菌感染中发挥重要作用,我们的结果进一步表明,NK-4可能为癌症免疫治疗提供一种潜在的治疗工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验